HIMS Today - Jul 14: Amazon's GLP-1 War Hits HIMS

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

HIMS Today - Jul 14: Amazon's GLP-1 War Hits HIMS

無料で聴く

ポッドキャストの詳細を見る

Hey, what’s up? It’s Joey here, your friendly neighborhood investor breaking down today’s market moves. Let’s talk about Hims & Hers, or HIMS for short. Today was a bit of a rough ride; the stock was down about 1.19%.

So, what happened? Well, it looks like HIMS got a little smoked after some news about Amazon ramping up its GLP-1 competition with Ozempic. Yeah, that one stung. Investors were clearly worried about how that might affect HIMS' growth, especially since they’re all about health and wellness products. When big players like Amazon step into the ring, it can get a bit dicey for smaller companies.

Now, why did people hit the sell button so fast? There’s been chatter around the whole AI healthcare scene, and with earnings calls coming up, folks are on high alert. HIMS is set to drop their Q2 results on August 10, and everyone’s trying to figure out if they’ll impress or flop. Plus, there was some buzz about insider share sales, which usually raises eyebrows. It’s like a little red flag that makes people think twice before holding onto their shares.

On a brighter note, HIMS did schedule that call to discuss their latest health platform results, which could be a big deal. If they have good stuff to share, it might just turn the tide for them. Just keep an eye on that.

So yeah, that’s the scoop on HIMS today. It was a tough day, but these things happen in the market. Remember, I’m just here to share what’s happening, not to give any financial advice. Catch you later!

まだレビューはありません